Clinical Trial Update: Folic Acid vs 5-methyltetrahydrofolate (5MTHF) in Recurrent Abortion [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 clinical trial comparing folic acid and 5-methyltetrahydrofolate in recurrent pregnancy loss has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pregnancy Loss

Drugs mentioned

• 5-methyltetrahydrofolate (5MTHF) (5-methyltetrahydrofolate)
• folic acid (folic acid)

Snippet

Sponsor: National Nutrition and Food Technology Institute | Conditions: Recurrent Abortion | Phase 2, Phase 3 | Status: COMPLETED